PTK2 and neoplasm: TENASCIN signaling (primarily Tenascin‐C, TNC) remodels the ECM and increases matrix stiffness via integrin–FAK/SRC and mechanotransduction pathways, activates YAP/TAZ, and consequently enhances tumor cell adhesion, migration, and immune exclusion [33].